TY - JOUR
T1 - Epitope Preservation Methods for Tissue Microarrays
AU - Andeen, Nicole K.
AU - Bowman, Regina
AU - Baullinger, Toni
AU - Brooks, J. Mathew
AU - Tretiakova, Maria S.
N1 - Funding Information:
Corresponding author: Nicole K. Andeen, MD, Dept of Pathology, Oregon Health & Science University, 3181 Sam Jackson Park Rd, Mailcode L113, Portland OR 97239; andeen@ ohsu.edu. This work was presented in part in poster form at the 2014 meeting of the United States and Canadian Academy of Pathology; March 1-7, 2014; San Diego, CA. Sources of support: Accountable Care Organization grant project, University of Washington. Pacific Northwest Prostate Cancer SPORE (P50 CA097186, PI: Peter Nelson). Acknowledgments: We thank Peter Nelson, MD, Pacific Northwest Prostate Cancer SPORE, and the Fred Hutchinson Experimental Histology Laboratory for image analysis scanning and support. We thank the Accountable Care Organization Grant Program at the University of Washington for financial support. We are grateful to Paul Swanson, MD, for his recommendations and critical review of this manuscript.
Publisher Copyright:
© American Society for Clinical Pathology, 2017.
PY - 2017/11/1
Y1 - 2017/11/1
N2 - Objectives We sought to test recent guidelines for preserving immunoreactivity of precut slides, to quantify loss of immunoreactivity, and to determine potential for preservation by altering storage conditions. Methods Precut slides from tissue microarrays were stored under one of several conditions: exposed to ambient air at room temperature, 4°C, or -20°C or in a vacuum-sealed container at room temperature, -20°C, -80°C, or with paraffin coating. At multiple intervals over 1 year, slides were stained with antibodies against p53, isocitrate dehydrogenase 1, Ki-67, synaptophysin, and androgen receptor and evaluated. Results Compared with time 0, the overall median percentage immunoreactivity was 66% at 6 months and 51% at 1 year. During the experiment, this was as low as 55% for precut slides stored in paraffin coating and up to 87% for those stored at -20°C. Vacuum sealing was an effective preservative for some antibody targets and detrimental for others. Storage at -80°C did not have added value. Conclusions For precut slides, there is a time, storage condition, and antibody-dependent loss of immunoreactivity that could compromise analysis of prognostic, predictive, and diagnostic markers. Our findings support previous recommendations and suggest that the best storage conditions are at -20°C, without paraffin coating or vacuum sealing.
AB - Objectives We sought to test recent guidelines for preserving immunoreactivity of precut slides, to quantify loss of immunoreactivity, and to determine potential for preservation by altering storage conditions. Methods Precut slides from tissue microarrays were stored under one of several conditions: exposed to ambient air at room temperature, 4°C, or -20°C or in a vacuum-sealed container at room temperature, -20°C, -80°C, or with paraffin coating. At multiple intervals over 1 year, slides were stained with antibodies against p53, isocitrate dehydrogenase 1, Ki-67, synaptophysin, and androgen receptor and evaluated. Results Compared with time 0, the overall median percentage immunoreactivity was 66% at 6 months and 51% at 1 year. During the experiment, this was as low as 55% for precut slides stored in paraffin coating and up to 87% for those stored at -20°C. Vacuum sealing was an effective preservative for some antibody targets and detrimental for others. Storage at -80°C did not have added value. Conclusions For precut slides, there is a time, storage condition, and antibody-dependent loss of immunoreactivity that could compromise analysis of prognostic, predictive, and diagnostic markers. Our findings support previous recommendations and suggest that the best storage conditions are at -20°C, without paraffin coating or vacuum sealing.
KW - Antibody
KW - Antigenicity
KW - Epitope
KW - Immunoreactivity
KW - Storage
KW - Tissue microarray
UR - http://www.scopus.com/inward/record.url?scp=85033554854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033554854&partnerID=8YFLogxK
U2 - 10.1093/ajcp/aqx062
DO - 10.1093/ajcp/aqx062
M3 - Article
C2 - 29106459
AN - SCOPUS:85033554854
SN - 0002-9173
VL - 148
SP - 380
EP - 389
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 5
ER -